Management will host a webcast and conference call on the same day at 5:00 pm Eastern Time to discuss the Company’s results for the fourth quarter and full year ended December 31, 2024.

Tourmaline Bio will announce Phase 2 trial results for pacibekitug on May 20, 2025, addressing chronic kidney disease.

HAMILTON, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- First Bank (Nasdaq Global Market: FRBA) invites participation in a conference call to discuss the Company’s financial and operating performance ...

JACKSONVILLE, FL / ACCESS Newswire / August 11, 2025 / GEE Group Inc. (NYSE American:JOB) (“the Company” or “GEE Group”), a provider of professional staffing services and human resource solutions, ...

Dell Technologies (NYSE: DELL) will conduct a conference call Thursday, Feb. 27, 2025, at 3:30 p.m. CST to discuss its fiscal 2025 fourth quarter and ...

Amarin Corporation plc announced a conference call scheduled for July 30, 2025, at 8:00 a.m. ET, to discuss its second quarter 2025 financial results and recent strategic initiatives, featuring ...

UN Press Release Nice, France, 9 June 2025 – The 2025 United Nations Ocean Conference, co-hosted by the Governments of France and Costa Rica, opened today in Nice with strong calls to accelerate ...

HAMILTON, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- First Bank (Nasdaq Global Market: FRBA) invites participation in a conference call to discuss the Company’s financial and operating performance ...